Definition of functionally and structurally distinct repressive states in the nuclear receptor PPARγ

Nat Commun. 2019 Dec 20;10(1):5825. doi: 10.1038/s41467-019-13768-0.

Abstract

The repressive states of nuclear receptors (i.e., apo or bound to antagonists or inverse agonists) are poorly defined, despite the fact that nuclear receptors are a major drug target. Most ligand bound structures of nuclear receptors, including peroxisome proliferator-activated receptor γ (PPARγ), are similar to the apo structure. Here we use NMR, accelerated molecular dynamics and hydrogen-deuterium exchange mass spectrometry to define the PPARγ structural ensemble. We find that the helix 3 charge clamp positioning varies widely in apo and is stabilized by efficacious ligand binding. We also reveal a previously undescribed mechanism for inverse agonism involving an omega loop to helix switch which induces disruption of a tripartite salt-bridge network. We demonstrate that ligand binding can induce multiple structurally distinct repressive states. One state recruits peptides from two different corepressors, while another recruits just one, providing structural evidence of ligand bias in a nuclear receptor.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Anilides / pharmacology
  • Benzamides / pharmacology
  • Binding Sites / drug effects
  • Binding Sites / genetics
  • Co-Repressor Proteins / metabolism*
  • Hydrogen Deuterium Exchange-Mass Spectrometry
  • Ligands
  • Magnetic Resonance Spectroscopy
  • Molecular Dynamics Simulation
  • Mutagenesis, Site-Directed
  • PPAR gamma / agonists
  • PPAR gamma / antagonists & inhibitors
  • PPAR gamma / metabolism*
  • PPAR gamma / ultrastructure
  • Peptides / metabolism*
  • Protein Conformation, alpha-Helical / drug effects
  • Protein Conformation, alpha-Helical / genetics
  • Pyridines / pharmacology
  • Rosiglitazone / pharmacology

Substances

  • 2-chloro-5-nitrobenzanilide
  • Anilides
  • Benzamides
  • Co-Repressor Proteins
  • Ligands
  • PPAR gamma
  • PPARG protein, human
  • Peptides
  • Pyridines
  • T 0070907
  • Rosiglitazone